Add Company
Join Now

Theratechnologies Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Theratechnologies's estimated annual revenue is currently $47.8M per year.(i)
  • Theratechnologies's estimated revenue per employee is $201,000

Employee Data

  • Theratechnologies has 238 Employees.(i)
  • Theratechnologies grew their employee count by 8% last year.

Theratechnologies's People

NameTitleEmail/Phone
1
Chief ChemistryReveal Email/Phone
2
VP & financesReveal Email/Phone
3
General Counsel and Corporate SecretaryReveal Email/Phone
4
VP, Global Regulatory Affairs, Quality Assurance and ComplianceReveal Email/Phone
5
VP US Commercial OperationsReveal Email/Phone
6
Field Medical Director, USReveal Email/Phone
7
Director, Information TechnologyReveal Email/Phone
8
Senior Director, Preclinical and Project ManagementReveal Email/Phone
9
SVP and Chief Medical OfficerReveal Email/Phone
10
SVP and Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.2M167%N/AN/A
#2
$30.2M1501%N/AN/A
#3
$10.7M1005%$39.7MN/A
#4
$104.3M51922%N/AN/A
#5
$47.8M238N/AN/AN/A
#6
$15.5M775%N/AN/A
#7
$395.8M19697%N/AN/A
#8
$187.3M9326%N/AN/A
#9
$361.6M17996%N/AN/A
#10
$27.5M1370%N/AN/A
Add Company

What Is Theratechnologies?

Theratechnologies (TSX: TH) is a specialty pharmaceutical Corporation that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor (GRF) peptides. Theratechnologies' strategy is to leverage its expertise in the field of metabolism and GRF peptides to address serious health disorders while remaining actively involved in the commercialization of its future products. Its first product, EGRIFTA (tesamorelin for injection), was approved by the United States Food and Drug Administration in November 2010. To date, EGRIFTA is the only approved therapy for the reduction of excess abdominal fat in people living with HIV.

keywords:N/A

N/A

Total Funding

238

Number of Employees

$47.8M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Theratechnologies News

2022-04-20 - Theratechnologies to Present at Bloom Burton & Co ...

MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX),...

2022-04-19 - Theratechnologies to Present at Bloom Burton & Co ...

MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$59.7M239-5%N/A
#2
$38.3M24045%N/A
#3
$15M2407%N/A
#4
$54.1M24018%N/A
#5
$55.4M24047%N/A